| abstract |
The present invention relates to pharmaceutical hormone compositions which can be administered orally, comprising a combined estrogen-progestogen mixture, which allows the co-administration of an estrogen component at a dose of 0.3-3 mg and a 19-norprogesterone derivative progestogen at a dose of 0.3-1.5 mg. or together with or in admixture with several non-toxic, inert, pharmaceutically acceptable carriers. SHE |